Yet another article. Getting a lot of press now
Post# of 148185
(Total Views: 603)
Posted On: 12/21/2020 10:24:38 PM
Yet another article. Getting a lot of press now
December 21, 2020
Kristi Rosa
Targeted Therapies in Oncology
"COVID-19 and Cancer Consortium (CCC19), which collects and analyzes data on adult patients who have received a diagnosis of COVID-19 and have a history of cancer or who currently have an invasive solid tumor or hematologic malignancy.
"We need to share some collective responsibility [to determine] how to preserve the cancer care enterprise during a pandemic and ensure that we’re not exchanging one public health crisis for another.”
"The therapeutic benefit of leronlimab, which has gained traction with the FDA for the treatment of breast malignancies,7 had been demonstrated in patients with COVID-19 in the recent phase 2 CD10 trial (NCT04343651) for mild-to-moderate symptoms of COVID-19.
https://www.targetedonc.com/view/nci-combats-covid-19-issues
December 21, 2020
Kristi Rosa
Targeted Therapies in Oncology
"COVID-19 and Cancer Consortium (CCC19), which collects and analyzes data on adult patients who have received a diagnosis of COVID-19 and have a history of cancer or who currently have an invasive solid tumor or hematologic malignancy.
"We need to share some collective responsibility [to determine] how to preserve the cancer care enterprise during a pandemic and ensure that we’re not exchanging one public health crisis for another.”
"The therapeutic benefit of leronlimab, which has gained traction with the FDA for the treatment of breast malignancies,7 had been demonstrated in patients with COVID-19 in the recent phase 2 CD10 trial (NCT04343651) for mild-to-moderate symptoms of COVID-19.
https://www.targetedonc.com/view/nci-combats-covid-19-issues
(2)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼